name: Removal (via snare/capture) and replacement of internally dwelling ureteral stent via percutaneous approach, including radiological supervision and interpretation


name: In-facility usual new Oriental medicine intake 20 minutes


name: In-facility detailed new Ayurvedic medicine intake 30 minutes


name: In-facility usual subsequent Oriental medicine intake 20 minutes


name: In-facility simple subsequent nutrition intake 10 minutes


name: In-facility detailed subsequent homeopathy intake 30 minutes


name: Metabolic interaction review each report


name: Endurance therapeutic exercise group each 15 minutes


name: Labor induction non-pharmaceutical each additional 15 minutes


name: Native American Healing sweat lodge group each session


name: Native American Healing treatment plan education family each 15 minutes


name: Eye medication administration newborn each treatment


name: Simple new 15 minutes in-office personal training intake


name: Comprehensive new 60 minutes in-office Native American Healing intake


name: Simple subsequent 15 minutes in-office nutrition intake


name: Simple subsequent 15 minutes in-office Native American Healing intake


name: Comprehensive prolonged subsequent 90 minutes in-office homeopathic intake


name: Comprehensive new out-of-office visit 60 minutes nutrition intake


name: Comprehensive new 60 minutes out-of-office Native American Healing intake


name: Simple subsequent 10 minutes out-of-office massage therapy intake


name: Usual subsequent 30 minutes out-of-office personal training intake


name: Usual subsequent out-of-office 30 minutes homeopathic intake


name: Perinatal death grief assistance individual each 15 minutes


name: Arterial peripherally inserted central catheter (PICC) injection each injection


name: Creating Optimum Health Through MindBodySpirit Integration(TM) (COHMI) Level I each program


name: Gastrointestinal oro-enteral tube insertion each placement


name: Radiology Diagnostics or Therapeutics Unit


name: three times a day at institution-specified times


name: Blood Volume Measurement Prefilled Syringes


name: Dictation Systems, Digital, Speech Recognition/Transcription


name: Physiologic Monitor Modules, Invasive Blood Pressure


name: Physiologic Monitor Modules, Pulse Oximetry


name: Chambers, Laboratory, Microarray Hybridization


name: Reader/Digitizers, Molecular Assay, Microarray


name: Physiologic Monitor Modules, Compressed Spectral Analysis (CSA)


name: Physiologic Monitor Modules, Capnography


name: Physiologic Monitor Modules, Arterial Blood Pressure


name: Saline Prefilled Syringes, Catheter Flush


name: Digital Intravascular Angiography Systems


name: Document Confidentiality Status - Restricted


name: Identity May Be Divulged - Not applicable


name: Prophylaxis against psychomotor agitation


name: CSF polymorphonuclear cell count decreased


name: Serum procollagen type I N-terminal propeptide increased


name: Administration of prophylactic drug or medicament for cardiovascular disorder


name: Ureterolysis, with or without repositioning of ureter for retroperitoneal fibrosis


name: Primary percutaneous transluminal mechanical thrombectomy, noncoronary, non-intracranial, arterial or arterial bypass graft, including fluoroscopic guidance and intraprocedural pharmacological thrombolytic injection(s); initial vessel


name: Laparoscopy, surgical; proctectomy, combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), with creation of colonic reservoir (eg, J-pouch), with diverting enterostomy, when performed


name: Transcatheter placement of intravascular stent(s), intracranial (eg, atherosclerotic stenosis), including balloon angioplasty, if performed


name: Cyclic citrullinated peptide antibody measurement


name: Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour


name: Unlisted therapeutic, prophylactic, or diagnostic intravenous or intra-arterial injection or infusion


name: Chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump


name: Service(s) provided between 10:00 PM and 8:00 AM at 24-hour facility, in addition to basic service


name: Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes


name: Asthma symptoms evaluated (includes documentation of numeric frequency of symptoms or patient completion of an asthma assessment tool/survey/questionnaire) (NMA-No Measure Associated)


name: Therapeutic exercise for the involved joint(s) instructed or physical or occupational therapy prescribed (OA)


name: Ablation, renal tumor(s), unilateral, percutaneous, cryotherapy


name: Arterial Mechanical Thrombectomy Procedures


name: Laparoscopic Bariatric Surgery Procedures


name: Internally Dwelling Renal Pelvis Catheter Introduction Procedures


name: Introduction Procedures on the Corpus Uteri


name: Initial and Continuing Intensive Care Services


name: Harvest of skin for tissue cultured skin autograft, 100 sq cm or less


name: Dermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (List separately in addition to code for primary procedure)


name: Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device and subcutaneous port components


name: Ablation, open, 1 or more renal mass lesion(s), cryosurgical, including intraoperative ultrasound guidance and monitoring, if performed


name: Endometrial sampling (biopsy) performed in conjunction with colposcopy (List separately in addition to code for primary procedure)


name: In-facility simple new Oriental medicine intake 10 minutes


name: In-facility usual new Ayurvedic medicine intake 20 minutes


name: In-facility simple subsequent Oriental medicine intake 10 minutes


name: In-facility detailed subsequent Ayurvedic medicine intake 30 minutes


name: In-facility usual subsequent homeopathy intake 20 minutes


name: Qualification provision informed consent no charge


name: Rossiter System(TM) individual each 15 minutes


name: Labor induction non-pharmaceutical initial 60 minutes


name: Native American Healing fluting therapy individual each 15 minutes


name: Native American Healing alcoholism treatment group each 60 minutes


name: Ventricular reservoir medication administration each 60 minutes


name: Detailed new 45 minutes in-office nutrition intake


name: Detailed new 45 minutes in-office Native American Healing intake


name: Comprehensive prolonged new 150 minutes in-office homeopathic intake


name: Comprehensive subsequent 60 minutes in-office personal training intake


name: Comprehensive subsequent 60 minutes in-office homeopathic intake


name: Detailed new out-of-office visit 45 minutes nutrition intake


name: Detailed new 45 minutes out-of-office Native American Healing intake


name: Comprehensive prolonged new out-of-office 150 minutes homeopathic intake


name: Simple subsequent 15 minutes out-of-office personal training intake


name: Simple subsequent out-of-office 15 minutes homeopathic intake


name: Venous peripherally inserted central catheter (PICC) infusion each infusion


name: Gastrointestinal naso-enteral tube insertion each placement


name: Postural exercise individual each 15 minutes


name: Physiologic Monitor Modules, Electrocardiography


name: Physiologic Monitor Modules, Transcutaneous Blood Gas


name: Image Storage Plates, Radiography, Mammography


name: Incubators, Laboratory, Thermocycling, Microarray


name: Physiologic Monitor Modules, Electroencephalography, Level-of-Consciousness


name: Physiologic Monitor Modules, Exhaled Gas Capnometry


name: Physiologic Monitor Modules, Pulmonary Artery Pressure


name: Heparin Prefilled Syringes, Catheter Flush


name: Information Systems, Data Management, Cardiology, Electrocardiography


name: Bone marrow basophilic leukocyte count increased


name: CSF polymorphonuclear cell count increased


name: Cholesterol absorption efficiency decreased


name: Serum procollagen type I C-terminal propeptide increased


name: Contrast injection(s) for radiologic evaluation of existing central venous access device, including fluoroscopy, image documentation and report


name: Laparoscopy, surgical; proctectomy, complete, combined abdominoperineal, with colostomy


name: Balloon angioplasty, intracranial (eg, atherosclerotic stenosis), percutaneous


name: Hemoglobin; glycosylated (A1C) by device cleared by FDA for home use


name: Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)


name: Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)


name: Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)


name: Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service


name: Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.


name: Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes


name: Clinical symptoms of volume overload (excess) assessed (NMA-No Measure Associated)


name: Initial examination of the involved joint(s) (includes visual inspection, palpation, range of motion) (OA) [Instructions: Report only for initial osteoarthritis visit or for visits for new joint involvement]


name: Gastrointestinal prophylaxis for NSAID use prescribed (OA)


name: Removal of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical (List separately in addition to code for primary procedure)


name: inert gas rebreathing for cardiac output measurement during rest


name: Renal Pelvis Catheter Introduction Procedures


name: Therapeutic, Prophylactic, and Diagnostic Injections and Infusions (Excludes Chemotherapy and Other Highly Complex Drug or Highly Complex Biologic Agent Administration)


name: Anesthesia for induced abortion procedures


name: Dermal autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 100 sq cm or less, or 1% of body area of infants and children


name: Delayed placement of distal extension prosthesis(es) from the level of the left subclavian artery to the celiac artery, after endovascular repair of descending thoracic aorta, including pre-procedure sizing and device selection, all nonselective catheterization(s), all associated radiological supervision and interpretation


name: Laparoscopy, surgical, gastric restrictive procedure; removal and replacement of adjustable gastric restrictive device component only


name: Laparoscopy, surgical, closure of enterostomy, large or small intestine, with resection and anastomosis


name: Revision (including removal) of prosthetic vaginal graft; vaginal approach


name: In-facility simple new massage therapy intake 10 minutes


name: In-facility simple new Ayurvedic medicine intake 10 minutes


name: In-facility detailed subsequent massage therapy intake 30 minutes


name: In-facility usual subsequent Ayurvedic medicine intake 20 minutes


name: In-facility simple subsequent homeopathy intake 10 minutes


name: Analysis and interpretation of laboratory findings each report


name: Sample non-prescription nutraceutical product dispensing no charge


name: Native American Healing singing therapy individual each 15 minutes


name: Native American Healing alcoholism treatment individual each 15 minutes


name: Total parenteral nutrition (TPN) administration each 60 minutes


name: Usual new 30 minutes in-office nutrition intake


name: Usual new 30 minutes in-office Native American Healing intake


name: Comprehensive prolonged new 120 minutes in-office homeopathic intake


name: Detailed subsequent 45 minutes in-office personal training intake


name: Detailed subsequent 45 minutes in-office homeopathic intake


name: Usual new out-of-office visit 30 minutes nutrition intake


name: Usual new 30 minutes out-of-office Native American Healing intake


name: Comprehensive prolonged new out-of-office 120 minutes homeopathic intake


name: Comprehensive subsequent out-of-office visit 60 minutes nutrition intake


name: Comprehensive subsequent 60 minutes out-of-office Native American Healing intake


name: Japanese meridian acupuncture each 15 minutes


name: Lactation counseling individual each 15 minutes


name: Stretching therapeutic exercise individual each 15 minutes


name: Image Digitization Systems, Computed Radiography, Dental


name: Physiologic Monitor Modules, Inspired Oxygen


name: Cassettes, Radiography, Image Plate, Mammography


name: Analyzers, Laboratory, Molecular Assay, Microarray


name: Molecular Microarrays, Mutation/Polymorphism, Gene CYP2D6/CYP2C19


name: Physiologic Monitor Modules, Intracranial Pressure (ICP)


name: Analyzers, Laboratory, Hematology, Cell Counting, Manual


name: Bone marrow polymorphonuclear leukocyte count increased


name: Haemoglobin distribution width decreased


name: Carbohydrate tolerance urine analysis decreased


name: Rotavirus neutralizing antibody positive


name: Surgical ventricular restoration procedure, includes prosthetic patch, when performed (eg, ventricular remodeling, SVR, SAVER, Dor procedures)


name: Ligation, division, and stripping, short saphenous vein


name: Repair of ileoanal pouch fistula/sinus (eg, perineal or vaginal), pouch advancement; transperineal approach


name: Chemodenervation of eccrine glands; other area(s) (eg, scalp, face, neck), per day


name: High energy neutron radiation treatment delivery, 1 or more isocenter(s) with coplanar or non-coplanar geometry with blocking and/or wedge, and/or compensator(s)


name: Pathology consultation during surgery; cytologic examination (eg, touch prep, squash prep), initial site


name: Zoster (shingles) vaccine (HZV), live, for subcutaneous injection


name: Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intra-arterial


name: Auditory rehabilitation; postlingual hearing loss


name: Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separately in addition to code for primary procedure)


name: Education and training for patient self-management by a nonphysician qualified health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 2-4 patients


name: Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.


name: New patient custodial care facility, group care, or assisted living visit, typically 75 minutes


name: Osteoarthritis assessed (OA) Includes assessment of all the following components: Osteoarthritis symptoms and functional status assessed (1006F) Use of anti-inflammatory or over-the-counter (OTC) analgesic medications assessed (1007F) Initial examination of the involved joint(s) (includes visual inspection, palpation, range of motion) (2004F)


name: Clinical signs of volume overload (excess) assessed (NMA-No Measure Associated)


name: Persistent asthma, preferred long term control medication or an acceptable alternative treatment, prescribed (NMA-No Measure Associated)


name: Extracorporeal shock wave performed by a physician, requiring anesthesia other than local, and involving the lateral humeral epicondyle


name: Quantitative sensory testing (QST), testing and interpretation per extremity; using other stimuli to assess sensation


name: Introduction Procedures on the Trachea and Bronchi


name: Other Laparoscopic Procedures on the Intestines Except Rectum


name: Diagnostic Radiology (Diagnostic Imaging) Procedures of the Vascular System


name: Education and Training for Patient Self-Management


name: Dermal autograft, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children


name: Tissue cultured skin autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; additional 1 sq cm to 75 sq cm (List separately in addition to code for primary procedure)


name: Incision and drainage, open, of deep abscess (subfascial), posterior spine; cervical, thoracic, or cervicothoracic


name: Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); initial extension


name: Laparoscopy, surgical, gastric restrictive procedure; revision of adjustable gastric restrictive device component only


name: Laparoscopy, surgical, colostomy or skin level cecostomy


name: Ablation, 1 or more renal tumor(s), percutaneous, unilateral, radiofrequency


name: In-facility usual new massage therapy intake 20 minutes


name: In-facility simple subsequent massage therapy intake 10 minutes


name: In-facility detailed subsequent reflexology intake 30 minutes


name: In-facility usual subsequent personal training intake 20 minutes


name: Undefined in-facility existing client without ICD diagnosis narrative required


name: Sample non-pharmaceutical product dispensing no charge


name: Native American Healing prayer individual each 15 minutes


name: Native American Healing vision and gazing therapy individual each 15 minutes


name: Intravenous chelation therapy administration each 60 minutes


name: Comprehensive new 60 minutes in-office personal training intake


name: Comprehensive new 60 minutes in-office homeopathic intake


name: Simple subsequent 15 minutes in-office personal training intake


name: Simple subsequent 15 minutes in-office homeopathic intake


name: Detailed new 30 minutes out-of-office massage therapy intake


name: Comprehensive new 60 minutes out-of-office personal training intake


name: Comprehensive new out-of-office 60 minutes homeopathic intake


name: Simple subsequent out-of-office visit 30 minutes nutrition intake


name: Usual subsequent 30 minutes out-of-office Native American Healing intake


name: Comprehensive prolonged subsequent out-of-office 120 minutes homeopathic intake


name: Permanent disability coping skills assistance group each 60 minutes


name: Breast-feeding education individual each 15 minutes


name: sodium chloride/sodium bicarbonate NASAL KIT


name: syringe,safety with needle,3 mL 20 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: needles, safety 19 gauge X 1 1/2" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 23 gauge X 1 1/2" MISCELL NEEDLE, DISPOSABLE


name: SUSPENSION, EXTENDED RELEASE, RECON (EA)


name: TABLET,EXTENDED RELEASE MULTIPHASE 12 HR


name: zinc sulfate heptahydrate 100 % MISCELL POWDER (GRAM)


name: Progesterone 10% Topical powder with Compounding Base, Stirring Stick


name: {2 (thyrotropin alfa 1.1 MG Injection [Thyrogen]) } Pack [Thyrogen Kit]


name: Octinoxate/Oxybenzone/Padimate O Topical application Cream


name: contraceptive barrier device, vented, non-latex


name: syringe,safety with needle,3 mL 20 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: infant formula iron,lac-free (hypoallergenic) no.1


name: needles, safety 18 gauge X 1" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 22 gauge X 1" MISCELL NEEDLE, DISPOSABLE


name: hydroxyethyl methacrylate 96 % MISCELL LIQUID (GRAM)


name: compounding vehicle suspension sugar-free no. 4


name: Avobenzone/Octinoxate/Octisalate/Oxybenzone 3%-7.5%-5%-6% Topical application Spray


name: {5 (Ifosfamide 50 MG/ML Injectable Solution [Ifex]) / 3 (Mesna 100 MG/ML Injectable Solution [Mesnex]) } Pack [Ifex / Mesnex Kit 5/3]


name: Flavocoxid 250 MG Oral Capsule [Limbrel]


name: Ostomy Care Preparation Topical application Cream


name: Eucalyptol/Menthol/Methyl Salicylate/Thymol Oromucosal Film


name: syringe,safety with needle,1 mL 26 gauge X 3/8" MISCELL SYRINGE, EMPTY DISPOSABLE


name: needles, safety 18 gauge X 1 1/2" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 22 gauge X 1 1/2" MISCELL NEEDLE, DISPOSABLE


name: mineral oil, light/petrolatum,white/cetyl alc/stearyl alc MISCELL OINTMENT (GRAM)


name: compounding vehicle suspension sugar-free no. 3


name: diagnostic drug contrast agent technetium Tc-99m medronate kit


name: Cream, Multi Ingredient Topical application Cream


name: Homeopathic Substance Topical application Gel/Jelly


name: Ointment, Multi Ingredient Topical application Ointment


name: Cleanser and Moisturizer Topical application Lotion


name: Ultrasound Preparation Topical application Lotion


name: needles, safety 21 gauge X 1" MISCELL NEEDLE, DISPOSABLE


name: infant form,iron,lac-fr,hypoal 22 gram-33 gram-33 gram-14.8 mg/100 gram ORAL POWDER (GRAM)


name: Rubidium Chloride Rb 82 Intravenous Kit [Cardiogen-82 Generator]


name: Contact Lens Product Ophthalmic Solution


name: Octinoxate/Octisalate/Oxybenzone Topical application Cream


name: Ultrasound Preparation Topical application Gel/Jelly


name: Lubricant;Lubricant NA; NA Topical application Gel/Jelly


name: Octinoxate/Oxybenzone/Padimate O Topical application Ointment


name: Homosalate/Octinoxate/Octisalate/Oxybenzone Topical application Lotion


name: Ostomy Care Preparation Topical application Lotion


name: Octinoxate/Octisalate Topical application Lotion


name: Nutritional Supplement Oral Powder for Solution


name: syringe,safety with needle,10 mL 20 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: needles, safety 21 gauge X 1 1/2" MISCELL NEEDLE, DISPOSABLE


name: nutritional therapy, impaired hepatic function


name: Avobenzone/Octinoxate/Octisalate/Oxybenzone 3%-5%-5%-6% Topical application Gel/Jelly


name: Avobenzone/Homosalate/Octinoxate/Oxybenzone 3%-8%-7.5%-6% Topical application Lotion


name: Octinoxate/Oxybenzone 4.0%-2.0% Topical application Lotion


name: Avobenzone/Octinoxate/Octisalate/Oxybenzone 3%-5%-5%-6% Topical application Cream


name: Ultrasound Preparation Topical application Cream


name: Octinoxate/Octisalate/Octocrylene/Oxybenzone Topical application Cream


name: Conducting Gel Topical application Gel/Jelly


name: Octinoxate/Octocrylene/Titanium Dioxide Topical application Lotion


name: syringe,safety with needle,10 mL 20 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: needles, safety 20 gauge X 1" MISCELL NEEDLE, DISPOSABLE


name: nut.therapy, phenylketonuria (PKU) with iron, no.1


name: Epinephrine 0.5 MG/1 ML Multiple Routes Kit


name: Homeopathic Substance Topical application Cream


name: Wound Care Preparation Topical application Gel/Jelly


name: Octinoxate/Octisalate Topical application Ointment


name: Octinoxate/Octocrylene/Oxybenzone/Titanium Dioxide Topical application Lotion


name: Cleanser and Disinfectant Topical application Pad


name: silver/calcium alginate 3/4" X 12" TOPICAL BANDAGE


name: syringe,safety with needle,5 mL 20 gauge X 1 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: needles, safety 19 gauge X 1" MISCELL NEEDLE, DISPOSABLE


name: CAPSULE,EXTENDED RELEASE MULTIPHASE 12HR


name: TABLET,EXTENDED RELEASE MULTIPHASE 24 HR


name: Duovisc Includes 0.35/0.4 & 0.5/0.55 Viscoelastic Kits


name: Technetium Tc 99m Albumin Aggregated Intravenous Kit


name: technetium Tc-99m pentetate kit (procedure)


name: Multimineral/Multivitamin Oral Tablet, Extended Release


name: Hydrophilic Ointment Topical application Ointment


name: Octinoxate/Octocrylene Topical application Lotion


name: Formula, Infant Oral Powder for Suspension


name: Homeopathic Substance Topical application Liquid


name: Cleanser and Moisturizer Topical application Oil


name: Wound Care Preparation Topical application Spray


name: Special acquisition of blood and blood products


name: Ostomy clamp, any type, replacement only, each


name: Brachytherapy source, non-stranded, ytterbium-169, per source


name: Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, prefabricated, includes fitting and adjustment


name: ACCESSORY, ARM TROUGH, WITH OR WITHOUT HAND SUPPORT, EACH


name: Manual wheelchair accessory, foam filled caster tire, any size, each


name: MANUAL WHEELCHAIR ACCESSORY, CASTER WHEEL EXCLUDES TIRE, ANY SIZE, REPLACEMENT ONLY, EACH


name: Physician service required to establish and document the need for a power mobility device


name: Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)


name: Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)


name: Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)


name: Controlled dose inhalation drug delivery system


name: Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, custom fabricated


name: Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Replacement socket, shoulder disarticulation/interscapular thoracic, molded to patient model, for use with or without external power


name: Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only


name: Emergency power source for use with electric ventricular assist device, replacement only


name: Holster for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant


name: Surgical techniques requiring use of robotic surgical system


name: Commode chair with integrated seat lift mechanism, electric, any type


name: Presbyopia correcting function of intraocular lens


name: SNOMED CT July 2005 Release: Edicion en Espanol 20051031


name: aluminum hydroxide, magnesium hydroxide, methylpolysiloxane, sorbitol drug combination


name: Ultrasound Preparation Topical application Pad


name: {21 (ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Ovral 28 Day]


name: Octinoxate/Oxybenzone/Padimate O Topical application Spray


name: Hair Care Preparation Topical application Spray


name: Cleanser and Moisturizer Topical application Liquid


name: Wound Care Preparation Topical application Powder


name: Physician providing a service in an unlisted health professional shortage area (hpsa)


name: Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology


name: Brachytherapy linear source, non-stranded, palladium-103, per 1 mm


name: Placement of endorectal intracavitary applicator for high intensity brachytherapy


name: Wheelchair accessory, cylinder tank carrier, each


name: Manual wheelchair accessory, foam filled propulsion tire, any size, each


name: Manual wheelchair accessory, propulsion wheel excludes tire, any size, replacement only, each


name: Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)


name: Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Antiemetic drug, rectal/suppository, not otherwise specified


name: Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type


name: Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise


name: Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Replacement socket, above elbow/elbow disarticulation, molded to patient model, for use with or without external power


name: Prosthetic donning sleeve, any material, each


name: Microprocessor control unit for use with electric ventricular assist device, replacement only


name: Power pack base for use with electric/pneumatic ventricular assist device, replacement only


name: Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral


name: Replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each


name: Pet imaging, any site, not otherwise specified


name: Hair Care Preparation Topical application Liquid


name: Oil, Multi Ingredient Topical application Oil


name: Padimate O/Petrolatum Topical application Stick


name: Competitive acquisition program, restocking of emergency drugs after emergency administration


name: Reaching/grabbing device, any type, any length, each


name: Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source


name: WHEELCHAIR ACCESSORY, CRUTCH AND CANE HOLDER, EACH


name: MANUAL WHEELCHAIR ACCESSORY, TUBE FOR PNEUMATIC CASTER TIRE, ANY SIZE, EACH


name: Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project)


name: Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)


name: Lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panel(s), lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, prefabricated, includes fitting and adjustment


name: Hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Replacement socket, below elbow/wrist disarticulation, molded to patient model, for use with or without external power


name: Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, acrylic material


name: Driver for use with pneumatic ventricular assist device, replacement only


name: Power pack base for use with electric ventricular assist device, replacement only


name: Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Power adapter for pneumatic ventricular assist device, replacement only, vehicle type


name: Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each


name: Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, free standing, complete with grab bar


name: cetearyl alcohol, Ceteareth-20 Bulk powder


name: Progesterone Wettable, compounding powder


name: Nutritional Supplement Oral Tablet, Chewable


name: Oil, Multi Ingredient Topical application Spray


name: Dimethicone/Padimate O Topical application Stick


name: Oxybenzone/Padimate O/Petrolatum Topical application Stick


name: Competitive acquisition program no-pay submission for a prescription number


name: Home glucose disposable monitor, includes test strips


name: Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source


name: Dynamic knee, extension/flexion device with active resistance control


name: MANUAL WHEELCHAIR ACCESSORY, PNEUMATIC CASTER TIRE, ANY SIZE, EACH


name: Manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each


name: Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary


name: Direct admission of patient for hospital observation care


name: Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)


name: Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project)


name: Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)


name: LUMBAR-SACRAL ORTHOSIS, SAGITTAL-CORONAL CONTROL, WITH RIGID POSTERIOR FRAME/PANEL(S), POSTERIOR EXTENDS FROM SACROCOCCYGEAL JUNCTION TO T-9 VERTEBRA, LATERAL STRENGTH PROVIDED BY RIGID LATERAL FRAME/PANEL(S), PRODUCES INTRACAVITARY PRESSURE TO REDUCE LOAD ON INTERVERTEBRAL DISCS, INCLUDES STRAPS, CLOSURES, MAY INCLUDE PADDING, STAYS, SHOULDER STRAPS, PENDULOUS ABDOMEN DESIGN, CUSTOM FABRICATED


name: Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Upper extremity addition, harness, triple control, simultaneous operation of terminal device and elbow


name: Addition to upper extremity prosthesis, above elbow disarticulation, acrylic material


name: External recharging system for battery (internal) for use with implantable neurostimulator, replacement only


name: Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only


name: Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Battery for pneumatic ventricular assist device, replacement only, each


name: Annual gynecological examination; clinical breast examination without pelvic evaluation


name: Arthroscopy of shoulder with biceps tenodesis


name: ENURESIS ALARM, USING AUDITORY BUZZER AND/OR VIBRATION DEVICE


name: Replacement battery, alkaline, j cell, for use with medically necessary home blood glucose monitor owned by patient, each


name: Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, attached to bed, with grab bar


name: Allantoin/Padimate O Topical application Stick


name: Oxybenzone/Padimate O Topical application Stick


name: Octinoxate/Oxybenzone/Padimate O 4.5%-4%-7% Topical application Stick


name: Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level


name: Compression burn mask, face and/or neck, plastic or equal, custom fabricated


name: radiation stereoscopic x-ray guidance for localization of target volume


name: Manual wheelchair accessory, insert for pneumatic propulsion tire (removable), any type, any size, each


name: Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each


name: Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)


name: Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)


name: Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)


name: Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise


name: Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Upper extremity prosthesis addition, flexion/extension wrist with or without friction, for use with external powered terminal device


name: Addition to upper extremity prosthesis, below elbow/wrist disarticulation, acrylic material


name: Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension


name: Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only


name: Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Mobility cart for pneumatic ventricular assist device, replacement only


name: Dispensing new spectacle lenses for patient supplied frame


name: Laparoscopic esophagomyotomy (heller type)


name: Replacement battery, alkaline (other than j cell), for use with medically necessary home blood glucose monitor owned by patient, each


name: Transcutaneous electrical joint stimulation device system, includes all accessories


name: Homeopathic Substance Sublingual Solution


name: Multimineral/Multivitamin Oral Capsule, Liquid Filled


name: Nutritional Supplement Oral Powder for Suspension


name: Conducting Gel Topical application Spray


name: Ethinyl estradiol 20 microgram and ferrous fumarate 75 mg and norethindrone 1 mg oral tablet


name: This service was performed in whole or in part by a resident in a department of veterans affairs medical center or clinic, supervised in accordance with va policy


name: Tubing with integrated heating element for use with positive airway pressure device


name: Standing frame/table system, mobile (dynamic stander), any size including pediatric


name: Manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each


name: Manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size, replacement only, each


name: Power wheelchair accessory, group 27 non-sealed lead acid battery, each


name: Smoking and tobacco use cessation counseling visit; intensive, greater than 10 minutes


name: Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project)


name: Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)


name: Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf


name: Addition to lower extremity, polycentric knee joint, for custom fabricated knee ankle foot orthosis, each joint


name: Elbow wrist hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: All lower extremity prosthesis, solid ankle cushion heel (sach) foot, replacement only


name: Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, ultralight material (titanium, carbon fiber or equal)


name: Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension


name: Monitor control cable for use with electric ventricular assist device, replacement only


name: Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only


name: Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Pharmacy dispensing fee for inhalation drug(s); per 30 days


name: Scleral lens, liquid bandage device, per lens


name: Gene expression profiling panel for use in the management of breast cancer treatment


name: Sterile saline or water, metered dose dispenser, 10 ml


name: Homeopathic Substance Topical application Powder


name: Cleanser and Moisturizer Topical application Soap


name: Shampoo, Multi Ingredient Topical application Shampoo


name: Avobenzone/Dimethicone/Octinoxate/Octisalate 3%-1%-7.5%-5% Topical application Stick


name: Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each


name: Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, custom fabricated, includes fitting and adjustment


name: WHEELCHAIR ACCESSORY, BEARINGS, ANY TYPE, REPLACEMENT ONLY, EACH


name: Manual wheelchair accessory, foam propulsion tire, any size, each


name: Manual wheelchair accessory, caster fork, any size, replacement only, each


name: Pharmacy dispensing fee for inhalation drug(s); per 90 days


name: Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)


name: Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each


name: Addition to halo procedure, magnetic resonance image compatible systems, rings and pins, any material


name: Elbow wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Finger orthosis, nontorsion joint, may include soft interface, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Addition to upper extremity prosthesis, below elbow/wrist disarticulation, ultralight material (titanium, carbon fiber or equal)


name: Implantable neurostimulator pulse generator, single array, rechargeable, includes extension


name: Monitor/display module for use with electric ventricular assist device, replacement only


name: Emergency power source for use with electric/pneumatic ventricular assist device, replacement only


name: Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only


name: Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period


name: Performance measurement, evaluation of patient self assessment, depression


name: Commode chair with integrated seat lift mechanism, non-electric, any type


name: Erythrocyte sedimentation rate - finding


name: Physiologic Monitor Modules, Temperature


name: Workstations, Digital Radiography, Dental


name: Analyzers, Laboratory, Clinical Chemistry/Immunoassay


name: Mammography Computed Radiography Systems


name: Physiologic Monitor Modules, Fraction of Inspired Oxygen (FiO2)


name: Physiologic Monitor Modules, Pulmonary Artery Wedge Pressure (PAWP)


name: Image Digitization Systems, Computed Radiography


name: Nebulizers, High-Frequency, Intrapulmonary Percussion


name: Expanded yes/no indicator - not applicable


name: Bone marrow eosinophilic leukocyte count increased


name: Anastomosis, cavopulmonary, second superior vena cava (List separately in addition to primary procedure)


name: Ligation, division, and stripping, long (greater) saphenous veins from saphenofemoral junction to knee or below


name: Repair of ileoanal pouch fistula/sinus (eg, perineal or vaginal), pouch advancement; combined transperineal and transabdominal approach


name: Blood, occult, by peroxidase activity (eg, guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening


name: Pathology consultation during surgery; cytologic examination (eg, touch prep, squash prep), each additional site (List separately in addition to code for primary procedure)


name: Intravenous infusion, hydration; initial, 31 minutes to 1 hour


name: Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug


name: Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report


name: Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professional, both face-to-face time with the patient and time interpreting test results and preparing the report; first hour


name: Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug


name: Education and training for patient self-management by a nonphysician qualified health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 5-8 patients


name: Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes


name: Level of activity assessed (NMA-No Measure Associated)


name: Anti-inflammatory/analgesic agent prescribed (OA) (Use for prescribed or continued medication[s], including over-the-counter medication[s])


name: Introduction Procedures on the Lymph Nodes and Lymphatic Channels


name: Introduction Procedures on the Intestines (Except Rectum)


name: Introduction Procedures on the Vas Deferens


name: Anesthesia for incomplete or missed abortion procedures


name: Dermal autograft, trunk, arms, legs; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (List separately in addition to code for primary procedure)


name: Tissue cultured skin autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 100 sq cm, or each additional 1% of body area of infants and children, or part thereof (List separately in addition to code for primary procedure)


name: Incision and drainage, open, of deep abscess (subfascial), posterior spine; lumbar, sacral, or lumbosacral


name: Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device component only


name: Laparoscopy, surgical, mobilization (take-down) of splenic flexure performed in conjunction with partial colectomy (List separately in addition to primary procedure)


name: In-facility detailed new massage therapy intake 30 minutes


name: In-facility usual subsequent massage therapy intake 20 minutes


name: In-facility simple subsequent Ayurvedic medicine intake 10 minutes


name: In-facility detailed subsequent personal training intake 30 minutes


name: Analysis and interpretation of computer data each report


name: Sample nutraceutical product dispensing no charge


name: Native American Healing touching therapy individual each 15 minutes


name: Native American Healing fanning therapy individual each 15 minutes


name: Intravenous oxidative medicine administration each 60 minutes


name: Simple new 15 minutes in-office nutrition intake


name: Comprehensive new 60 minutes in-office nutrition intake


name: Comprehensive prolonged new 90 minutes in-office homeopathic intake


name: Usual subsequent 30 minutes in-office personal training intake


name: Usual subsequent 30 minutes in-office homeopathic intake


name: Simple new out-of-office visit 15 minutes nutrition intake


name: Simple new 15 minutes out-of-office Native American Healing intake


name: Comprehensive prolonged new out-of-office 90 minutes homeopathic intake


name: Detailed subsequent out-of-office visit 45 minutes nutrition intake


name: Detailed subsequent 45 minutes out-of-office Native American Healing intake


name: Comprehensive prolonged subsequent out-of-office 150 minutes homeopathic intake


name: Permanent disability coping skills assistance family each 15 minutes


name: Ashiatsu Oriental Bar Therapy(TM) each 15 minutes


name: syringe with needle,disposable, 1 mL 21 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety with needle,5 mL 20 gauge X 1" MISCELL SYRINGE, EMPTY DISPOSABLE


name: needles, safety 20 gauge X 1 1/2" MISCELL NEEDLE, DISPOSABLE


name: CAPSULE,EXTENDED RELEASE MULTIPHASE 24HR


name: nut. tx, impaired digestive fxn with soy & fiber#2


name: emollient combination no. 2 MISCELL OINTMENT (GRAM)


name: nutritional therapy, elemental, lactose-free


name: Octinoxate/Octisalate/Oxybenzone 7.5%-5.0%-5.0% Topical application Lotion


name: Benzethonium Chloride;Petrolatum 0.13%; 98.79% Topical application Kit


name: Conducting Gel Topical application Cream


name: Ethylhexyl Salicylate/Octinoxate/Octocrylene/Oxybenzone Topical application Lotion


name: Lotion, Multi Ingredient Topical application Liquid


name: Cleanser and Moisturizer Topical application Spray


name: Conducting Gel Topical application Liquid


name: Ethinyl estradiol 30 microgram and ferrous fumarate 75 mg and norethindrone 1.5 mg oral tablet


name: Item provided without cost to provider, supplier or practitioner, or full credit received for replaced device (examples, but not limited to, covered under warranty, replaced due to defect, free samples)


name: Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), without filter, each


name: Standing frame/table system, multi-position (e.g., three-way stander), any size including pediatric, with or without wheels


name: Manual wheelchair accessory, pneumatic propulsion tire, any size, each


name: Manual wheelchair accessory, foam caster tire, any size, each


name: Power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell, absorbed glassmat), each


name: Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes


name: CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIDEPRESSANT MEDICATION DURING THE ENTIRE 12 WEEK ACUTE TREATMENT PHASE MEASURE


name: Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)


name: Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)


name: Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)


name: Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)


name: Antiemetic drug, oral, not otherwise specified


name: Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each


name: Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, medial lateral rotation control, with or without free motion ankle, custom fabricated


name: Elbow wrist hand finger orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment


name: Ankle, symes, molded to patient model, socket without solid ankle cushion heel (sach) foot, replacement only


name: Addition to upper extremity prosthesis, above elbow disarticulation, ultralight material (titanium, carbon fiber or equal)


name: Implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension


name: Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Emergency power supply cable for use with electric ventricular assist device, replacement only


name: Filters for use with electric or electric/pneumatic ventricular assist device, replacement only


name: Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period


name: Genetic counseling, under physician supervision, each 15 minutes


name: Home infusion services provided in the infusion suite of the iv therapy provider


name: Seat lift mechanism placed over or on top of toilet, any type


name: Fluoroscopic gastrointestinal tract loopography


name: Intravenous Drip Route of Administration


name: mitotic spindle orientation checkpoint signaling


name: Administer - dosing instruction imperative


name: 2nd course treatment.surgery.other regional disease:Prid:Pt:Cancer.XXX:Nom


name: oocyte localization involved in germarium-derived egg chamber formation


name: Cast care education, guidance, and counseling


name: Multiple drug resistant organism:Prid:Pt:Urine:Nom


name: G protein-coupled adenosine receptor signaling pathway


name: control of blood pressure by circulatory renin-angiotensin


name: brain-derived neurotrophic factor receptor signaling pathway


name: locomotion involved in locomotory behavior


name: regulation of systemic arterial blood pressure by hormone


name: Injection of radiological dye into ventricle of brain


name: Systematized Nomenclature of Medicine Clinical Terms


name: Hepatitis C virus RNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp.sig


name: Views^W water soluble contrast PO:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:RF


name: Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02:Prid:Pt:Cancer.XXX:Nom


name: Surgery of other regional site(s), distant site(s) or distant lymph nodes 98-02:Prid:Pt:Cancer.XXX:Nom


name: 2nd course treatment.hormonal therapy:Prid:Pt:Subsequent cancer Rx:Nom


name: 4th course treatment.surgery:Prid:Pt:Subsequent cancer Rx:Nom


name: 4th course treatment.radiation:Prid:Pt:Subsequent cancer Rx:Nom


name: 4th course treatment.biological response modifier therapy:Prid:Pt:Subsequent cancer Rx:Nom


name: Phosphatidylserine Ab.IgA & IgG & IgM panel:-:Pt:Ser:-


name: Acetaldehyde & Paraldehyde panel:MCnc:Pt:Ser/Plas:Qn


name: Herpes simplex virus 1 Ab:PrThr:Pt:Ser:Ord


name: Imipramine & Desipramine panel:-:Pt:Ser/Plas:Qn


name: clomiPRAMINE & Norclomipramine panel:-:Pt:Ser/Plas:Qn


name: Height measurement device panel:-:Pt:^Patient:-


name: Blood pressure device panel:-:Pt:^Patient:-


name: Guidance for localization of placenta:Find:Pt:Pelvis>Uterus:Doc:CT


name: Guidance for drainage of abscess+placement of drainage catheter:Find:Pt:Abdomen+Pelvis>Appendix:Doc:US


name: Inflammatory bowel disease Ab panel:-:Pt:Ser:Qn


name: Human papilloma virus high & Low risk DNA panel:-:Pt:Cvx:-


name: Multiple drug resistant organism:Prid:Pt:Sputum:Nom


name: GALT gene allele 2:Arb:Pt:Bld:Ord:Molgen


name: Vesicular stomatitis New Jersey virus Ab:Titr:Pt:Ser:SemiQn


name: Polio virus 3 Ab:Titr:Pt:Body fld:SemiQn


name: Legionella pneumophila 1 Ab.IgM:Titr:Pt:CSF:SemiQn


name: Jamestown canyon virus Ab.IgG:Titr:Pt:Ser:SemiQn


name: Herpes virus 7 Ab.IgM:Titr:Pt:Ser:SemiQn


name: Herpes virus 7 Ab.IgG:Titr:Pt:Ser:SemiQn


name: Event description.crime &or intentional harm/Patient disappearance


name: External rotation.active range of motion


name: Geographic information system coordinate quality


name: Coxiella burnetii phase 1 & 2 Ab.IgM panel


name: Fluoroscopic angiography of ovarian artery with contrast


name: Do not take indigestion remedies or medicines containing iron or zinc at the same time of day as this medicine


name: Fluoroscopic angiography with contrast and embolization of hepatic artery


name: Fluoroscopic angiography with contrast and embolization of iliac artery


name: CT angiography of carotid artery with contrast


name: Fluoroscopic angiography with contrast and embolization of bronchial artery


name: Fluoroscopic angiography with contrast and embolization of internal iliac artery


name: Cardiac care education, guidance, and counseling


name: Ranson's criteria score (assessment scale)


name: Eastern equine encephalitis virus Ab.IgM:PrThr:Pt:CSF:Ord:IA


name: Saint Louis encephalitis virus Ab.IgM:PrThr:Pt:CSF:Ord:IA


name: View PA && View AP:Find:Pt:Chest && Abdomen:Doc:XR


name: NAACCR ambiguous terminology as basis for diagnosis:Prid:Pt:Cancer.XXX:Nom


name: Date of diagnosis of multiple tumors:TmStp:Pt:Cancer.XXX:Qn


name: Number of tumors at diagnosis:Num:Pt:Cancer.XXX:Qn


name: Scope of regional lymph node surgery 98-02:Prid:Pt:Cancer.XXX:Nom


name: 2nd course treatment.surgery:Prid:Pt:Subsequent cancer Rx:Nom


name: Vanillylmandelate & Creatinine panel:-:24H:Urine:-


name: Neuronal nuclear type 3 Ab:PrThr:Pt:Ser:Ord


name: Immunoglobulin light chains panel:-:24H:Urine:Qn


name: Bile acid fractions panel:SCnc:Pt:Ser/Plas:Qn


name: California encephalitis virus Ab:ACnc:Pt:Ser:Ord


name: HbA1c measurement device panel:-:Pt:^Patient:-


name: Calcium hydrogen phosphate dihydrate:SatFr:24H:Urine:Qn


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:MR


name: Views^W Tc-99m tagged WBC IV:Find:Pt:XXX>Bone:Doc:NM


name: Guidance for injection:Find:Pt:Chest>Pleural space:Doc:US


name: Views^W In-111 tagged WBC IV:Find:Pt:Whole body:Doc:NM


name: AML+MDS gene 7q31 deletion:Prid:Pt:Bld/Tiss:Nom:Molgen


name: AML+MDS gene CEP 8 trisomy:Arb:Pt:Bld/Tiss:Ord:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen


name: Clindamycin:Susc:Pt:Isolate:OrdQn:Agar diffusion.erythromycin induced resistance


name: ERBB2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Mitogen-Activated protein kinase 3 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: MYC gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Yersinia enterocolitica O:5,27 Ab:Titr:Pt:Ser:SemiQn


name: Vesicular stomatitis Indiana virus Ab:Titr:Pt:Ser:SemiQn


name: Trypanosoma brucei rhodesiense Ab:Titr:Pt:Ser:SemiQn


name: Salmonella typhi H Ab:Titr:Pt:Ser:SemiQn


name: Porcine reproductive and respiratory syndrome virus Ab:Titr:Pt:Ser:SemiQn


name: Parainfluenza virus 1 Ab^2nd specimen:Titr:Pt:Ser:SemiQn


name: Histoplasma capsulatum Ab:PrThr:Pt:Plr fld:Ord


name: Event description.procedure &or treatment &or surgery


name: Coxiella burnetii phase 1 & 2 Ab.IgG panel


name: Saint Louis encephalitis virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: Views && view PA:Find:Pt:Chest>Ribs.right && Chest:Doc:XR


name: Multiple tumors reported as single primary:Prid:Pt:Cancer.XXX:Nom


name: Systemic therapy &or surgery sequence:Prid:Pt:Cancer.XXX:Nom


name: 2nd course treatment.biological reponse modifier therapy:Prid:Pt:Subsequent cancer Rx:Nom


name: 2nd course treatment.other therapy:Prid:Pt:Subsequent cancer Rx:Nom


name: 3rd course treatment.surgery:Prid:Pt:Subsequent cancer Rx:Nom


name: 3rd course treatment.radiation:Prid:Pt:Subsequent cancer Rx:Nom


name: 3rd course treatment.chemotherapy:Prid:Pt:Subsequent cancer Rx:Nom


name: 4th course treatment.chemotherapy:Prid:Pt:Subsequent cancer Rx:Nom


name: Fluoxetine & Norfluoxetine panel:MCnc:Pt:Ser/Plas:Qn


name: Doxepin & Nordoxepin panel:-:Pt:Ser/Plas:Qn


name: Nicotine & Metabolites panel:MCnc:Pt:Urine:Qn


name: Brucella abortus Ab.IgG & IgM panel:-:Pt:Ser:-


name: Calcidiol & Calciferol & Calcitriol panel:MCnc:Pt:Ser/Plas:Qn


name: Oxygen saturation device panel:-:Pt:^Patient:-


name: Blood coagulation device panel:-:Pt:^Patient:-


name: Mycobacterium tuberculosis complex genotype:Prid:Pt:Isolate:Nar


name: Alkaline phosphatase.heat labile/Alkaline phosphatase.total:CFr:Pt:Ser/Plas:Qn:Heat stability


name: Staphylococcus sp.oxacillin resistant isolate:PrThr:Pt:Isolate:Ord:LA


name: Aspergillus sp Ab:Imp:Pt:Ser:Nar:Immune diffusion


name: Streptococcus pneumoniae serotype Ab.IgG:Imp:Pt:Ser:Nar


name: Multiple drug resistant organism:Prid:Pt:Wound:Nom


name: Neisseria meningitidis serogroup C Ab.IgG:MCnc:Pt:Ser:Qn


name: Jamestown canyon virus Ab:Titr:Pt:Ser:SemiQn


name: Histoplasma capsulatum mycelial phase Ab:Titr:Pt:Body fld:SemiQn


name: Event description.environmental hazard &or safety


name: External rotation.passive range of motion


name: Follow-up (referred to) provider &or specialist, network location indicator


name: Number of tumors & histologies:Num:Pt:^Patient:Qn


name: Scope of regional lymph node surgery at this facility 98-02:Prid:Pt:Cancer.XXX:Nom


name: 2nd course treatment.radiation:Prid:Pt:Subsequent cancer Rx:Nom


name: 3rd course treatment.hormonal therapy:Prid:Pt:Subsequent cancer Rx:Nom


name: 3rd course treatment.other therapy:Prid:Pt:Subsequent cancer Rx:Nom


name: 4th course treatment.other therapy:Prid:Pt:Subsequent cancer Rx:Nom


name: Recurrence distant site 1:Anat:Pt:Cancer.XXX:Nom


name: Amitriptyline & Nortriptyline panel:-:Pt:Ser/Plas:Qn


name: Mycoplasma sp & Ureaplasma sp panel:-:Pt:XXX:-:Organism specific culture


name: Metanephrine & Normetanephrine panel:MCnc:Pt:Ser/Plas:Qn


name: Peak flow meter device panel:-:Pt:^Patient:-


name: Metabolism measurement device panel:-:Pt:^Patient:-


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:MR


name: Multisection:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:MR


name: Views^W In-111 tiuxetan IV:Find:Pt:Whole body:Doc:NM


name: Borrelia burgdorferi Ab.IgG & IgM:Imp:Pt:CSF:Nom


name: Views for AV shunt^W radionuclide IV:Find:Pt:XXX:Doc:NM


name: CCND1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Epidermal growth factor receptor.phosphorylated Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Insulin-like growth factor-I receptor Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Mitogen-Activated protein kinase 14 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Mitogen-Activated protein kinase 8 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Mitogen-Activated protein kinase 9 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Retinoblastoma protein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Trial name:-:-:^Clinical trial protocol:Nar


name: Polio virus 2 Ab:Titr:Pt:Body fld:SemiQn


name: Parainfluenza virus 4 Ab.IgG:PrThr:Pt:Ser:Ord


name: Neisseria meningitidis serogroup A Ab.IgG:MCnc:Pt:Ser:Qn


name: Jamestown canyon virus Ab.IgM:Titr:Pt:Ser:SemiQn


name: Jamestown canyon virus Ab.IgG:Titr:Pt:XXX:SemiQn


name: Histoplasma capsulatum yeast phase Ab:Titr:Pt:Body fld:SemiQn


name: Epidermal growth factor receptor.phosphorylated Ag


name: Recurrence distant site 2:Prid:Pt:Cancer.XXX:Nom


name: Recurrence distant site 3:Prid:Pt:Cancer.XXX:Nom


name: Collaborative staging site-specific factor 6:Prid:Pt:Cancer.XXX:Nom


name: Derived American Joint Committee on Cancer conversion method:Arb:Pt:Cancer.XXX:Ord


name: Comorbidities and complications 6:Prid:Pt:^Patient:Nom


name: Hematologic transplant & endocrine procedures:Type:Pt:Cancer.XXX:Nom


name: Palliative procedure at facility.XXX:Type:Pt:Cancer.XXX:Nom


name: Name of follow-up contact:Pn:Pt:^Patient:Nom


name: Stage.summary & regional lymph nodes positive override flag:Arb:Pt:Cancer case.XXX:Ord


name: Stage.summary & distant metastasis 1 override flag:Arb:Pt:Cancer case.XXX:Ord


name: COC site & type override flag:Arb:Pt:Cancer case.XXX:Ord


name: Hospital sequence & site override flag:Arb:Pt:Cancer case.XXX:Ord


name: Follow-up contact supplemental information:Prid:Pt:^Patient:Nom


name: Derived American Joint Committee on Cancer M:Prid:Pt:Cancer.XXX:Nom


name: Derived American Joint Committee on Cancer M descriptor:Prid:Pt:Cancer.XXX:Nom


name: Archive facility identification number:ID:Pt:Cancer.XXX:Nom


name: Comorbidities and complications 8:Prid:Pt:^Patient:Nom


name: Comorbidities and complications 9:Prid:Pt:^Patient:Nom


name: Comorbidities and complications 10:Prid:Pt:^Patient:Nom


name: Date of surgical discharge:TmStp:Pt:Cancer.XXX:Qn


name: Deprecated Bacteria identified in Isolate


name: Herpes simplex virus 1+2 Ab.IgM:ACnc:Pt:Ser:Qn


name: Herpes simplex virus 1 Ab:Titr:Pt:Ser:SemiQn


name: Herpes simplex virus 1+2 Ab:Titr:Pt:CSF:SemiQn


name: Feline leukemia virus Ab:Titr:Pt:Ser:SemiQn


name: Colorado tick fever virus Ab.IgG:PrThr:Pt:Ser:Ord


name: Coccidioides immitis Ab:Titr:Pt:Plr fld:SemiQn


name: Clostridioides difficile toxin Ab:Titr:Pt:Ser:SemiQn


name: Guidance for percutaneous biopsy.core needle


name: Hospital sequence number & diagnostic confirmation override flag


name: Human papilloma virus high & Low risk DNA panel


name: Guidance for percutaneous drainage of abscess+placement of drainage catheter:Find:Pt:Chest:Doc:RF


name: Guidance for percutaneous aspiration of fluid:Find:Pt:Neck>Thyroid gland:Doc:US


name: Views for tumor^W radionuclide IV:Find:Pt:Whole body:Doc:NM


name: Views^W radionuclide IV:Find:Pt:Whole body:Doc:NM


name: Number of specimens received:Num:Pt:XXX:Qn


name: Coxiella burnetii phase 1 Ab.IgM:ACnc:Pt:Ser:Qn:IF


name: Employment education, guidance, and counseling


name: Feeding procedures education, guidance, and counseling


name: Food education, guidance, and counseling


name: Fluoroscopic angiography of popliteal artery with contrast


name: Fluoroscopic angiography of vertebral artery with contrast


name: Fluoroscopic angiography of splenic artery with contrast


name: Hospital sequence number & diagnostic confirmation override flag:Arb:Pt:Cancer case.XXX:Ord


name: Primary site & TNM-stage group override flag:Arb:Pt:Cancer case.XXX:Ord


name: Collaborative staging lymph nodes:Type:Pt:Cancer.XXX:Nom


name: Derived American Joint Committee on Cancer N descriptor:Prid:Pt:Cancer.XXX:Nom


name: Derived American Joint Committee on Cancer stage group:Prid:Pt:Cancer.XXX:Nom


name: Derived SEER summary stage 2000 conversion method:Arb:Pt:Cancer.XXX:Ord


name: Comorbidities and complications 7:Prid:Pt:^Patient:Nom


name: Readmission to the same hospital within 30D of surgical discharge:Arb:Pt:Cancer.XXX:Ord


name: Palliative procedure at this facility:Type:Pt:Cancer.XXX:Nom


name: Comorbidities and complications 1:Prid:Pt:^Patient:Nom


name: Age at first pregnancy:Time:Pt:^Patient:Qn


name: Herpes simplex virus 2 Ab.IgM:Titr:Pt:Body fld:SemiQn


name: Herpes simplex virus 2 Ab:Titr:Pt:CSF:SemiQn


name: Coxsackievirus A9 Ab:Titr:Pt:Body fld:SemiQn


name: Coxsackievirus A10 Ab:Titr:Pt:Body fld:SemiQn


name: Coxiella burnetii phase 1 Ab:Titr:Pt:Ser:SemiQn


name: Chlamydia trachomatis D+K Ab.IgM:Titr:Pt:Ser:SemiQn


name: Canine distemper virus Ab.IgG:Titr:Pt:CSF:SemiQn


name: Guidance for percutaneous replacement of cholecystostomy


name: Internal rotation.active range of motion


name: View AP for scoliosis^W standing + W R-bending:Find:Pt:Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:XR


name: Multisection for graft:Find:Pt:Upper extremity.left>Upper extremity vessel:Doc:US.doppler


name: Homemaking education, guidance, and counseling


name: Interaction education, guidance, and counseling


name: Legal system education, guidance, and counseling


name: CDC (Centers for Disease Control and Prevention) SWC (surgical wound classification) category


name: Fluoroscopic venography of superior vena cava with contrast and insertion of stent


name: Fluoroscopy guided percutaneous transluminal angioplasty of mesenteric artery with contrast


name: Fluoroscopic angiography with contrast and thrombolysis of intracranial artery


name: Views for shunt patency:Find:Pt:XXX:Doc:XR


name: Views^W DOBUTamine+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM


name: Deprecated Tibia Left & Fibula Left X-ray


name: Number of specimens obtained:Num:Pt:XXX:Qn


name: Stage.summary & TNM-N override flag:Arb:Pt:Cancer case.XXX:Ord


name: Derived American Joint Committee on Cancer T:Prid:Pt:Cancer.XXX:Nom:Derived


name: Derived American Joint Committee on Cancer N:Prid:Pt:Cancer.XXX:Nom


name: Derived SEER summary stage 2000:Prid:Pt:Cancer.XXX:Nom


name: Comorbidities and complications 2:Prid:Pt:^Patient:Nom


name: Comorbidities and complications 3:Prid:Pt:^Patient:Nom


name: Comorbidities and complications 4:Prid:Pt:^Patient:Nom


name: Comorbidities and complications 5:Prid:Pt:^Patient:Nom


name: Site coding system.current:Type:Pt:Cancer.XXX.anatomic site:Nom


name: Vendor serial number:ID:Pt:Laboratory device:Nom


name: Herpes virus 6 Ab.IgG:Titr:Pt:CSF:SemiQn


name: Herpes virus 6 Ab.IgM:Titr:Pt:CSF:SemiQn


name: Herpes simplex virus 2 Ab.IgM:PrThr:Pt:CSF:Ord


name: Herpes simplex virus 2 Ab:Titr:Pt:Ser:SemiQn


name: Coxsackievirus A16 Ab:Titr:Pt:Body fld:SemiQn


name: Chlamydia trachomatis D+K Ab.IgG:Titr:Pt:Ser:SemiQn


name: Chlamydia trachomatis D+K Ab.IgA:Titr:Pt:Ser:SemiQn


name: Canine distemper virus Ab.IgM:Titr:Pt:CSF:SemiQn


name: Hematologic transplant & endocrine procedures


name: View^W contrast PO:Find:Pt:Abdomen>Gastrointestinal tract.upper+Small bowel+Gallbladder:Doc:RF


name: Coxsackievirus A Ab panel:Titr:Pt:Ser:SemiQn:Comp fix


name: Gait training education, guidance, and counseling


name: housing education, guidance, and counseling


name: Fluoroscopic angiography of lower limb artery with contrast


name: Finding of secondary sexual characteristics


name: Do not take with any other paracetamol products


name: Guidance for drainage of abscess+placement of drainage catheter:Find:Pt:Abdomen>Liver:Doc:US


name: Views AP + lateral frog:Find:Pt:Pelvis & Lower extremity.bilateral>Hip:Doc:XR


name: Deprecated Tibia Right & Fibula Right X-ray


name: Number of specimens tested:Num:Pt:XXX:Qn


name: Insulin^pre 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Bovine leukemia virus Ab:Titr:Pt:Ser:SemiQn


name: Deprecated Fungus identified in Unspecified specimen by Culture


name: Growth/development education, guidance, and counseling


name: Lab findings education, guidance, and counseling


name: Fluoroscopic angiography of celiac artery with contrast and insertion of stent


name: Fluoroscopy guided angioplasty of splenic artery with contrast


name: Fluoroscopic angiography of thoracic aorta with contrast


name: Surgical inferior margin is closest uninvolved margin to ductal carcinoma in situ


name: Fluoroscopy guided percutaneous transluminal angioplasty of infrapopliteal artery with contrast


name: Ability to verbalize: medication refill plans


name: Fluoroscopic angiography of iliac artery with contrast


name: Surgical lateral margin is closest uninvolved margin to malignant neoplasm


name: Pediatric intensive care (qualifier value)


name: Ultrasound angiography of peripheral artery


name: Herpes simplex virus 1 Ab:Titr:Pt:CSF:SemiQn


name: Eastern equine encephalitis virus Ab.IgM:PrThr:Pt:CSF:Ord


name: Deprecated Clostridium tetani toxin Ab [Units/volume] in Serum


name: Guidance for percutaneous aspiration of cyst


name: Guidance for percutaneous drainage of abscess


name: Internal rotation.passive range of motion


name: Phosphatidylserine Ab.IgA & IgG & IgM panel


name: Rickettsia typhi & Rickettsia spotted fever group Ab.IgG & IgM panel


name: Multisection cine for CSF flow:Find:Pt:Head>Brain:Doc:MR


name: Human papilloma virus 6+11+42+43+44 DNA:PrThr:Pt:Cvx:Ord:Probe.amp.sig


name: Partial coherence interferometry biometer


name: Surgical deep margin involved by ductal carcinoma in situ


name: Fluoroscopic angiography of abdominal vascular structure with contrast


name: Fluoroscopic venography of azygos vein with contrast


name: Fluoroscopic angiography of external iliac artery with contrast


name: Loading machinery accident in water transport


name: Surgical medial margin is closest uninvolved margin to ductal carcinoma in situ


name: Ability to verbalize: reduction of medication compliance barriers plan


name: Fluoroscopic venography with contrast and embolization of testicular vein


name: Surgical superior margin involved by ductal carcinoma in situ


name: Fluoroscopic angiography with contrast and embolization of upper limb artery


name: Borrelia burgdorferi C6 Ab:ACnc:Pt:CSF:Qn


name: Bluetongue virus 2 Ab:Titr:Pt:Ser:SemiQn


name: Bluetongue virus 17 Ab:Titr:Pt:Ser:SemiQn


name: Bluetongue virus 10 Ab:Titr:Pt:Ser:SemiQn


name: Blastomyces dermatitidis Ab:Titr:Pt:Plr fld:SemiQn


name: COL3A1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Leishmania sp Ab.IgG & IgM panel:-:Pt:Ser:-


name: Herpes simplex virus Ab panel:-:Pt:Ser:-


name: 2nd course treatment.surgery.other regional disease


name: Accession number & class of case & sequence number override flag


name: NAACCR facility identification system coding system


name: Multisection transabdominal + transvaginal


name: Do not take indigestion remedies at the same time of day as this medicine


name: Fluoroscopic angiography of celiac artery with contrast


name: Fluoroscopic angiography with contrast and embolization of aortic arch


name: Fluoroscopic angiography of liver and portal venous system


name: Verbalizes discharge instructions regarding activity plan


name: Silicone intubation of nasolacrimal system


name: Piperazine-derivative calcium channel blocker


name: Allow to dissolve under the tongue. Do not transfer from this container. Keep tightly closed. Discard eight weeks after opening


name: Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab:Titr:Pt:Ser:SemiQn


name: Nuclear Ab pattern.smooth nuclear envelope:Titr:Pt:Body fld:SemiQn


name: Cyclic citrullinated peptide Ab.IgG:PrThr:Pt:Ser:Ord


name: Borrelia burgdorferi C6 Ab:ACnc:Pt:Ser:Qn


name: Bluetongue virus 11 Ab:Titr:Pt:Ser:SemiQn


name: Multiple tumors reported as single primary


name: Streptococcus pneumoniae 7 serotypes Ab.IgG panel B


name: Environment education, guidance, and counseling


name: Collaborative staging metastasis at diagnosis


name: Collaborative staging site-specific factor 3


name: Bordetella pertussis Ab.IgA & IgG & IgM panel


name: RHD gene allele & RHCE gene allele:Geno:Pt:Bld/Tiss:Nom:Molgen


name: Fluoroscopic venography of renal transplant


name: Examination AND/OR history taking - action


name: Fluoroscopic venography of upper limb with contrast


name: Fluoroscopic venography of female genital tract


name: Fluoroscopic angiography and embolization of artery of lower limb with contrast


name: Surgical deep margin is closest uninvolved margin to malignant neoplasm


name: Sjogrens syndrome-A & B extractable nuclear Ab panel


name: Exercises education, guidance, and counseling


name: Family planning education, guidance, and counseling


name: Magnetic resonance imaging of thoracolumbar spine


name: CT arthrography of metacarpophalangeal joint


name: Magnetic resonance angiography of vascular structure of neck


name: Rickettsia (Proteus) Ab panel:-:Pt:Ser:Qn


name: (View oblique) + (Views AP + lateral^W standing):Find:Pt:Lower extremity>Foot:Doc:XR


name: Rest/sleep education, guidance, and counseling


name: Exposure to potentially harmful entity, undetermined intent


name: CDC (Centers for Disease Control and Prevention) SWC (surgical wound classification) finding


name: Magnetic resonance imaging angiography of cardiac ventricles (procedure)


name: Warning. May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink


name: Medication set-up education, guidance, and counseling


name: Nuclear Ab pattern.speckled:Titr:Pt:Body fld:SemiQn


name: Referral lab name:ID:Pt:Referral lab test:Nar


name: Sulfatide Ab.IgG & Ab.IgM panel:-:Pt:Ser:Qn


name: Colorado tick fever virus Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Galactose 1 phosphate uridyl transferase:CCnc:Pt:Bld.dot:Qn


name: Aspergillus sp Ab:Titr:Pt:Plr fld:SemiQn


name: Eastern equine encephalitis virus Ab.IgM:PrThr:Pt:XXX:Ord


name: Sjogrens syndrome-A & B extractable nuclear Ab panel:-:Pt:Ser:-


name: 17-Ketosteroids & 17-Ketogenic steroids panel


name: 2nd course treatment.biological reponse modifier therapy


name: NAACCR hispanic identification algorithm hispanic origin


name: Bordetella pertussis & Bordetella parapertussis DNA panel


name: Study observation.general transvaginal 1st trimester


name: Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free


name: Hepatitis B virus S+pol gene:Prid:Pt:Ser/Plas:Nom:Probe.amp.tar


name: Positioning education, guidance, and counseling


name: Screening education, guidance, and counseling


name: Fluoroscopic angiography with contrast and drainage of heart


name: CT angiography of lower limb artery with contrast


name: Avoid exposure of skin to direct sunlight or sun lamps


name: Fluoroscopic cardiac ventriculography (procedure)


name: Pregnancy section:-:-:^FDA package insert:Nar


name: Guidance for drainage of abscess+placement of chest tube:Find:Pt:Chest>Pleural space:Doc:CT


name: Guidance for drainage of abscess+placement of drainage catheter:Find:Pt:Pelvis:Doc:CT


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Abdomen>Retroperitoneum:Doc:CT


name: Readmission to the same hospital within 30D of surgical discharge


name: View AP for scoliosis^W standing in brace:Find:Pt:Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:XR


name: Guidance for drainage of cyst+placement of drainage catheter:Find:Pt:Abdomen>Kidney:Doc:US


name: Polymerase chain reaction test for Leishmania infantum


name: Revision of anastomosis between lacrimal drainage system and nose


name: Surgical deep margin is closest uninvolved margin to ductal carcinoma in situ


name: Doppler ultrasonography of iliac and femoral arteries


name: Fluoroscopic angiography of celiac artery and mesenteric artery with contrast


name: Ability to verbalize: medication administration routine


name: Streptococcus pneumoniae 23f Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: Drug abuse and dependence section:-:-:^FDA package insert:Nar


name: SPL unclassified section:-:-:^FDA package insert:Nar


name: Acetylcholine receptor ganglionic neuronal Ab:SCnc:Pt:Ser:Qn


name: Salmonella & Shigella sp:Prid:Pt:XXX:Nom:Organism specific culture


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen+Pelvis:Doc:CT


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney:Doc:CT


name: Allopurinol & Oxipurinol panel:MCnc:Pt:Ser/Plas:Qn


name: Calcidiol & Calciferol & Calcitriol panel


name: Cancer-Directed surgery at this facility 98-02


name: Deprecated Measles virus IgG Ab [Presence] in Cerebral spinal fluid


name: Nuclear lens fragment in anterior chamber


name: Fluoroscopic angiography of renal transplant with contrast


name: Magnetic resonance angiography of coronary artery


name: Wellness health education, guidance, and counseling


name: Arbitrary unit of IgG isotype for phospholipid antigen


name: Spiritual care education, guidance, and counseling


name: Health promotion education, guidance, and counseling


name: Surgical lateral margin is closest uninvolved margin to ductal carcinoma in situ


name: Do not take anything containing aspirin while taking this medicine


name: SPL patient package insert section:-:-:^FDA package insert:Nar


name: SPL medguide section:-:-:^FDA package insert:Nar


name: Guidance for percutaneous biopsy^W contrast IV:Find:Pt:XXX:Doc:CT


name: Views for blood flow^W radionuclide IV:Find:Pt:Abdomen>Liver:Doc:NM


name: Multisection^WO & W contrast IV:Find:Pt:Chest+Abdomen:Doc:CT


name: Guidance for drainage of abscess+placement of drainage catheter:Find:Pt:Abdomen+Pelvis>Appendix:Doc:CT


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Abdomen>Pancreas:Doc:CT


name: 17-Ketosteroids & 17-Ketogenic steroids panel:-:24H:Urine:Qn


name: (View Sunrise) + (views^W standing):Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Fluoroscopic angiography with contrast and thrombolysis of femoral artery


name: Fluoroscopic angiography of pelvic vascular structure


name: Fluoroscopy guided percutaneous transluminal angioplasty of upper limb artery with contrast


name: Fluoroscopic angiography of tibial artery with contrast